Altre lingue Aarti Drugs Limited

Azioni

AARTIDRUGS

INE767A01016

Tempo differito Bombay S.E. Altri mercati azionari 12:00:47 25/04/2024			Variaz. 5gg	Var. 1 gen.
500,4 ^INR	-0,18%		+1,44%	+2,32%

29/03	Aarti Drugs Limited annuncia la cessazione dei dirigenti	CI
31/01	Aarti Drugs inizia la produzione di prodotti dermatologici nello stabilimento di Tarapur, India	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Aarti Drugs Limited Announces Executive Cessation	29/03
Aarti Drugs Begins Manufacturing Dermatology Products in Tarapur, India Facility	31/01
Aarti Drugs Limited Initiates Commercial Production of Dermatology Product At New Facility in Tarapur, Maharashtra	30/01
Aarti Drugs Limited Announces Interim Dividend for the Financial Year 2023- 24	24/01
Aarti Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	24/01
Aarti Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	19/10/23
Tranche Update on Aarti Drugs Limited's Equity Buyback Plan announced on July 21, 2023.	28/08/23
Aarti Drugs Limited's Equity Buyback announced on July 21, 2023, has closed with 665,000 shares, representing 0.72% for INR 598.5 million.	17/08/23
Aarti Drugs Clocks Gains in Fiscal Q1 Consolidated Profit	24/07/23
Aarti Drugs Limited announces an Equity Buyback for 665,000 shares, representing 0.72% for INR 598.5 million.	21/07/23
Aarti Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	21/07/23
Aarti Drugs Limited authorizes a Buyback Plan.	21/07/23
Aarti Drugs Limited's Board intends to launch an Equity Buyback on July 21, 2023.	14/07/23
Aarti Drugs Limited's Board intends to launch an Equity Buyback on July 21, 2023.	14/07/23
Aarti Drugs' Consolidated Profit Climbs in Fiscal Q4	01/05/23
Aarti Drugs Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	29/04/23
Aarti Drugs' Consolidated Net Profit Declines in Fiscal Q3	30/01/23
Aarti Drugs Limited Declares Interim Dividend for the Financial Year 2022-23	27/01/23
Aarti Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	27/01/23
Aarti Drugs : Loss of Share Certificates	28/12/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Aarti Drugs Limited

Azioni

AARTIDRUGS

INE767A01016

Altre lingue

Filtri